Company / R&D per Share
FILANA THERAPEUTICS, INC. R&D per Share History
FY2011-FY2015 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D per Share
$0.11
FY2015
5-year range
$0.11 / $0.49
FY2011-FY2015
Trend
-35.7%
vs FY2014
Sector context
Sector data unavailable
Latest sector comparison
What the data says
R&D per Share has declined for 4 consecutive years, from $0.49 in FY2011 to $0.11 in FY2015.
Based on SEC 10-K filings.
0.11 in FY2015 with a 3-year CAGR of -32.7%.
Declined from $0.18 to $0.11 over the past 2 years.
R&D per Share over time
Growth rates
- 3-Year CAGR
- -32.7%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- FILANA THERAPEUTICS, INC.'s r&d per share has declined for 4 consecutive years.
- In FY2015, r&d per share decreased 35.7% year-over-year.
- Peak r&d per share was recorded in FY2011.
Company context
Key Data Points
- Altman Z-Score 3.76 (safe zone, above 2.9 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2015 | $0.11 | -35.7% |
| FY2014 | $0.17 | -8.7% |
| FY2013 | $0.18 | -48.0% |
| FY2012 | $0.35 | -28.3% |
| FY2011 | $0.49 | - |
As of FY2015 · SEC 10-K · Updated Jun 24, 2026